Surrogacy process

A comprehensive collection of common questions about IVF in China, from interpretation of examination indicators and process steps to clinical decisions, systematically addressing core issues such as ovarian reserve assessment, ovulation stimulation protocols, embryo culture, and transfer timing, providing professional reference for those preparing for pregnancy.

China's Assisted Reproductive Technology Management Regulations impose strict access management on medical institutions performing IVF, artificial insemination, and other technologies. This article explains the scope of application, institutional qualification requirements, ethical review standards, technical operation restrictions, and penalties for violations, helping patients understand the compliant medical treatment process and their rights protection.

Ovulation induction in China typically takes 10-14 days, depending on the protocol, medication response, and age. This article details the complete process, time differences by age, key monitoring indicators, and precautions to help patients plan treatment scientifically.

ICSI (Intracytoplasmic Sperm Injection) is the core technology of second-generation IVF in China, primarily addressing male factor infertility. This article analyzes suitable conditions, specific procedures, risks, and precautions from a physician's decision-making perspective, helping patients accurately determine if their condition is applicable.

In domestic IVF treatment, prescription medications such as ovulation induction drugs and luteal support drugs are prescribed by the reproductive center; patients do not need to bring them themselves. This article details the classification, effects, usage, and precautions of commonly used medications during the IVF cycle, helping patients correctly understand the medication process and avoid medication misunderstandings.

In China, IVF babies have the same legal rights to household registration as naturally conceived babies and can be registered with either the father or mother. This article details required documents, procedures, and common questions to help parents complete their baby's registration smoothly. No special approval is needed; registration is done with the birth medical certificate.

An objective comparison of China-US IVF differences across technology, success rates, costs, legal environment, and process experience. Analyze respective advantages and target populations to help make informed decisions based on individual circumstances.

Patients with chromosomal abnormalities can undergo IVF in China primarily through Preimplantation Genetic Testing (PGT). Suitable candidates include carriers of structural and numerical abnormalities. The specific plan depends on the type of abnormality, age, ovarian function, and other factors. PGT-A is used for aneuploidy screening, while PGT-SR is for structural rearrangement carriers.

Natural Cycle IVF in China uses little or no ovulation-stimulating medication during a woman's natural menstrual cycle, monitoring follicle development via ultrasound and hormones before egg retrieval. This article analyzes suitable candidates, specific procedures, advantages, limitations, and clinical considerations from a reproductive doctor's perspective to help patients rationally assess treatment fit.

IVF treatment is outpatient-based and does not require hospitalization; you can go home during treatment. The arrangements for ovarian stimulation, egg retrieval, and embryo transfer vary, and planning should be based on hospital distance and physical condition. A reproductive doctor explains the procedures and precautions for each stage in detail.

Whether the next cycle can be started immediately after IVF failure depends on the presence of frozen embryos, ovarian recovery, endometrial condition, and the cause of the previous failure. This article analyzes interval recommendations, key recovery points, and timing for reattempt from a reproductive medicine perspective.

Pre-IVF examinations in China include fertility assessments for both partners, infectious disease screening, and chromosome testing. This article details the checklist, schedule, validity periods, and precautions to help those planning IVF treatment understand the entire preparation process.

Embryo donation in China is strictly regulated by law, only allowing the donation of embryos formed from donated eggs, and must comply with fertility policies, medical indications, and ethical review. This article provides a detailed interpretation of legal conditions, application procedures, medical institution qualification requirements, and common risks to help you accurately understand current regulations and practical boundaries.

Addressing the question 'Can I still work after IVF in China?', this article analyzes the actual impact of ovulation induction, egg retrieval, and embryo transfer on work based on the physical condition and time requirements of each stage of IVF treatment. It provides work schedule suggestions for different occupational groups to help patients reasonably arrange treatment and work.

After a positive IVF pregnancy test, continued luteal support, regular monitoring of HCG doubling and progesterone levels, timely ultrasound to confirm fetal heartbeat, and appropriate referral to obstetrics for record filing are essential. This article details the complete post-IVF success process, check-up items, schedule, and precautions to help patients navigate early pregnancy smoothly.

IVF costs vary due to individual differences, hospital grade, treatment plans, and other factors. This article systematically outlines cost composition and budgeting methods from examination, ovulation induction, egg retrieval, embryo culture to transfer, helping patients plan finances reasonably and avoid hidden expenses.

Whether Chinese patients with chromosomal abnormalities can undergo PGT depends on the type of abnormality, genetic counseling results, and center qualifications. PGT-SR is suitable for structural abnormalities such as balanced translocations and Robertsonian translocations, while PGT-A is suitable for advanced maternal age or recurrent miscarriage patients. This article, based on the physician's decision-making logic, outlines indications, policy restrictions, procedural steps, and common misconceptions.

In China, a complete IVF cycle typically takes 2-3 months. This article breaks down the duration of each stage—preliminary checks, ovulation induction, egg retrieval, embryo culture, and transfer—from a timeline perspective, analyzing how age, hospital, and protocol affect the cycle, helping you plan your medical visits effectively.

The hospital with the most annual assisted reproduction cycles in China is CITIC Xiangya Reproductive and Genetic Hospital, with over 50,000 cycles per year. This article reviews the annual cycle rankings of major domestic reproductive centers, analyzes the reasons for differences between hospitals, helps understand the true meaning behind cycle numbers, and provides an objective reference for selection.

The birth medical certificate for an IVF baby is exactly the same as for a naturally conceived baby, with no mention of assisted reproduction. This article provides a detailed application process, required documents, time requirements, and common FAQs to help IVF families smoothly obtain their baby's first legal document.